down arrow

OptimizeRx Corp.

  • Market Cap: Micro Cap
  • Industry: Software Products
  • ISIN: US68401U2042
  • NASDAQ: OPRX
USD
7.60
-0.02 (-0.26%)

Sep 23

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
CoreCard Corp.
Innovid Corp.
ReposiTrak, Inc.
OptimizeRx Corp.
SOPHiA GENETICS SA
Quantum-Si, Inc.
Blacksky Technology, Inc.
Ryvyl, Inc.
RADCOM Ltd.
FTC Solar, Inc.
2U, Inc.

Why is OptimizeRx Corp. ?

1
The company has declared negative results in Jun'2026 after 4 consecutive positive quarters
  • NET SALES(Q) At USD 20.5 MM has Fallen at -29.77%
  • OPERATING PROFIT(Q) Lowest at USD 0.98 MM
  • OPERATING PROFIT MARGIN(Q) Lowest at 4.76 %
2
Underperformed the market in the last 1 year
  • Even though the market (S&P 500) has generated returns of 15.76% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -60.13% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Software Products)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is OptimizeRx Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
OptimizeRx Corp.
-60.13%
-0.46
73.08%
S&P 500
15.76%
1.20
13.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
20.37%
EBIT Growth (5y)
50.16%
EBIT to Interest (avg)
-4.63
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
0.60
Tax Ratio
4.37%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
0.97
EV to EBIT
10.47
EV to EBITDA
7.71
EV to Capital Employed
0.97
EV to Sales
1.15
PEG Ratio
0.16
Dividend Yield
NA
ROCE (Latest)
9.22%
ROE (Latest)
4.19%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 18.68 MM

DEBT-EQUITY RATIO (HY)

Lowest at -3.52 %

RAW MATERIAL COST(Y)

Fallen by -18.88% (YoY

NET PROFIT(9M)

Higher at USD 4.07 MM

-23What is not working for the Company
NET SALES(Q)

At USD 20.5 MM has Fallen at -29.77%

OPERATING PROFIT(Q)

Lowest at USD 0.98 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 4.76 %

PRE-TAX PROFIT(Q)

Lowest at USD -1.1 MM

NET PROFIT(Q)

Lowest at USD -0.7 MM

EPS(Q)

Lowest at USD -0.04

Here's what is working for OptimizeRx Corp.

Operating Cash Flow
Highest at USD 18.68 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debt-Equity Ratio
Lowest at -3.52 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -18.88% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for OptimizeRx Corp.

Net Sales
At USD 20.5 MM has Fallen at -29.77%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely negative

Net Sales (USD MM)

Pre-Tax Profit
At USD -1.1 MM has Fallen at -163.98%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -0.7 MM has Fallen at -145.89%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Profit
Lowest at USD 0.98 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Operating Profit Margin
Lowest at 4.76 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at USD -1.1 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -0.7 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

EPS
Lowest at USD -0.04
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Footer loading